Clinical Trials

294 enrolled

Nasopharyngeal Carcinoma

NCT04509726 2026-01-20

EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma

9 enrolled

Nasopharyngeal Carcinoma

NCT03267498 2026-01-12

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

40 enrolled 14 charts

Nasopharyngeal Carcinoma

NCT04227509 2025-12-31

Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

53 enrolled

Nasopharyngeal Carcinoma

NCT04004871 2025-12-11

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

60 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02795195 2025-08-07

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

51 enrolled

Nasopharyngeal Carcinoma

NCT03984357 2025-07-17

PLATINUM

152 enrolled

Nasopharyngeal Carcinoma

NCT04833257 2025-07-08

Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC

63 enrolled

Nasopharyngeal Carcinoma

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

236 enrolled

Nasopharyngeal Carcinoma, Body Weight

NCT06251050 2025-05-30

A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy

175 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Stomatitis

NCT05741008 2025-04-27

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

20 enrolled

Nasopharyngeal Carcinoma

NCT05834712 2025-01-27

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

224 enrolled

Nasopharyngeal Carcinoma

NCT04996758 2024-12-12

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

40 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT02538510 2024-11-26

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

50 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Salivary Gland Neoplasms

NCT04417985 2024-08-21

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

112 enrolled

Nasopharyngeal Carcinoma

NCT05330169 2024-07-17

Hearing Impairment of Nasopharyngeal Carcinoma

200 enrolled

Nasopharyngeal Carcinoma

NCT04995185 2024-05-16

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

9 enrolled

Nasopharyngeal Carcinoma, Hypoxia, Nasopharyngeal Neoplasms

NCT04396886 2024-05-09

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

38 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT03025958 2024-05-06

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT06367049 2024-04-16

Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal Carcinoma

470 enrolled

Nasopharyngeal Carcinoma

NCT03788499 2024-02-23

Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis

160 enrolled

Nasopharyngeal Carcinoma

NCT06244394 2024-02-06

Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma

230 enrolled

Nasopharyngeal Carcinoma

NCT05918224 2024-02-05

Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

160 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Stomatitis

NCT03906058 2023-10-25

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

39 enrolled

Nasopharyngeal Carcinoma

NCT03598218 2023-08-03

Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT00834093 2023-06-28

A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

18 enrolled 9 charts

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT03429868 2023-05-10

PET and MRI in Prognosis Prediction of NPC

180 enrolled

Nasopharyngeal Carcinoma

NCT02940925 2023-04-12

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

241 enrolled

Nasopharyngeal Carcinoma

NCT04350190 2023-01-13

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

25 enrolled

Nasopharyngeal Carcinoma

NCT04636632 2022-11-07

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 1 Completed

100 enrolled

Nasopharyngeal Carcinoma

NCT02460419 2022-10-28

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

104 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00188253 2022-10-18

Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.

30 enrolled

Nasopharyngeal Carcinoma

NCT02143388 2022-08-31

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

180 enrolled

Nasopharyngeal Carcinoma

NCT04834206 2022-05-10

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

32 enrolled

Nasopharyngeal Carcinoma

NCT04508816 2022-04-04

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

45 enrolled

Nasopharyngeal Carcinoma

NCT02562599 2022-02-22

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

60 enrolled

Nasopharyngeal Carcinoma

NCT02237924 2022-02-14

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT02642107 2021-11-05

NPC-CTVn

446 enrolled

Nasopharyngeal Carcinoma

NCT00592501 2021-10-26

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

25 enrolled 16 charts

Nasopharyngeal Carcinoma

NCT04394065 2021-09-17

uEXPLORER Total-body PET/CT in Nasopharyngeal Carcinoma

56 enrolled

Nasopharyngeal Carcinoma

NCT05020067 2021-08-25

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

90 enrolled

Nasopharyngeal Carcinoma

NCT03379610 2021-04-30

A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy

426 enrolled

Nasopharyngeal Carcinoma

NCT03668366 2021-02-11

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

133 enrolled

Nasopharyngeal Carcinoma

NCT03601390 2020-12-19

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

387 enrolled

Nasopharyngeal Carcinoma

NCT03989297 2020-09-02

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

104 enrolled

Nasopharyngeal Carcinoma

NCT02575547 2020-07-30

Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients

186 enrolled

Nasopharyngeal Carcinoma, Malnutrition

NCT03670342 2020-04-30

Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer

20 enrolled

Nasopharyngeal Carcinoma

NCT01344356 2020-04-10

Stereotactic Body Radiotherapy for Head and Neck Tumors

Phase 4 Completed

19 enrolled 10 charts